nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—CA14—Zoledronate—Paget's disease of bone	0.278	0.364	CbGbCtD
Celecoxib—CA12—Zoledronate—Paget's disease of bone	0.198	0.259	CbGbCtD
Celecoxib—CA2—Zoledronate—Paget's disease of bone	0.16	0.209	CbGbCtD
Celecoxib—PTGS2—Risedronate—Paget's disease of bone	0.129	0.169	CbGbCtD
Celecoxib—MAPK14—RANKL/RANK Signaling Pathway—TNFRSF11A—Paget's disease of bone	0.00154	0.0445	CbGpPWpGaD
Celecoxib—PDPK1—Downstream TCR signaling—INPP5D—Paget's disease of bone	0.0014	0.0406	CbGpPWpGaD
Celecoxib—PDPK1—Interleukin-11 Signaling Pathway—BGLAP—Paget's disease of bone	0.00138	0.04	CbGpPWpGaD
Celecoxib—PDPK1—Class I PI3K signaling events—INPP5D—Paget's disease of bone	0.0013	0.0377	CbGpPWpGaD
Celecoxib—PDPK1—Insulin Pathway—INPP5D—Paget's disease of bone	0.0013	0.0377	CbGpPWpGaD
Celecoxib—PDPK1—TGF-beta receptor signaling—PML—Paget's disease of bone	0.0012	0.0348	CbGpPWpGaD
Celecoxib—PDPK1—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00117	0.0339	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling—INPP5D—Paget's disease of bone	0.00105	0.0303	CbGpPWpGaD
Celecoxib—MAPK14—Monoamine Transport—TNFRSF11B—Paget's disease of bone	0.00103	0.0299	CbGpPWpGaD
Celecoxib—PDPK1—mTOR signaling pathway—PML—Paget's disease of bone	0.000993	0.0287	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling in naïve CD4+ T cells—INPP5D—Paget's disease of bone	0.000958	0.0277	CbGpPWpGaD
Celecoxib—PDPK1—BCR signaling pathway—INPP5D—Paget's disease of bone	0.000947	0.0274	CbGpPWpGaD
Celecoxib—MAPK14—EPO signaling pathway—INPP5D—Paget's disease of bone	0.000889	0.0257	CbGpPWpGaD
Celecoxib—PDPK1—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—INPP5D—Paget's disease of bone	0.000822	0.0238	CbGpPWpGaD
Celecoxib—PDPK1—CXCR4-mediated signaling events—INPP5D—Paget's disease of bone	0.00079	0.0229	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.000704	0.0204	CbGpPWpGaD
Celecoxib—MAPK14—RANKL/RANK Signaling Pathway—TNFRSF11B—Paget's disease of bone	0.00067	0.0194	CbGpPWpGaD
Celecoxib—MAPK14—FGF signaling pathway—BGLAP—Paget's disease of bone	0.00061	0.0176	CbGpPWpGaD
Celecoxib—MAPK14—IL-4 Signaling Pathway—INPP5D—Paget's disease of bone	0.000585	0.0169	CbGpPWpGaD
Celecoxib—PDPK1—BDNF signaling pathway—ALPL—Paget's disease of bone	0.000578	0.0167	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—ALPL—Paget's disease of bone	0.000561	0.0162	CbGpPWpGaD
Celecoxib—MAPK14—Kit receptor signaling pathway—INPP5D—Paget's disease of bone	0.000545	0.0158	CbGpPWpGaD
Celecoxib—MAPK14—IL4-mediated signaling events—INPP5D—Paget's disease of bone	0.000523	0.0151	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of retinoblastoma protein—BGLAP—Paget's disease of bone	0.000519	0.015	CbGpPWpGaD
Celecoxib—MAPK14—IL-1 signaling pathway—SQSTM1—Paget's disease of bone	0.000516	0.0149	CbGpPWpGaD
Celecoxib—MAPK14—RANKL/RANK Signaling Pathway—SQSTM1—Paget's disease of bone	0.000516	0.0149	CbGpPWpGaD
Celecoxib—MAPK14—BCR signaling pathway—INPP5D—Paget's disease of bone	0.000492	0.0142	CbGpPWpGaD
Celecoxib—PDPK1—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000467	0.0135	CbGpPWpGaD
Celecoxib—PDPK1—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.00046	0.0133	CbGpPWpGaD
Celecoxib—MAPK14—p73 transcription factor network—PML—Paget's disease of bone	0.000447	0.0129	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—BGLAP—Paget's disease of bone	0.000437	0.0126	CbGpPWpGaD
Celecoxib—CA9—Cellular responses to stress—VCP—Paget's disease of bone	0.000418	0.0121	CbGpPWpGaD
Celecoxib—Confusional state—Etidronic acid—Paget's disease of bone	0.000384	0.00192	CcSEcCtD
Celecoxib—Sinusitis—Risedronate—Paget's disease of bone	0.000383	0.00191	CcSEcCtD
Celecoxib—Muscle spasms—Alendronate—Paget's disease of bone	0.000382	0.00191	CcSEcCtD
Celecoxib—Infection—Etidronic acid—Paget's disease of bone	0.000378	0.00189	CcSEcCtD
Celecoxib—Stomatitis—Pamidronate—Paget's disease of bone	0.000378	0.00189	CcSEcCtD
Celecoxib—Pancytopenia—Zoledronate—Paget's disease of bone	0.000377	0.00188	CcSEcCtD
Celecoxib—Conjunctivitis—Pamidronate—Paget's disease of bone	0.000377	0.00188	CcSEcCtD
Celecoxib—Urinary tract infection—Pamidronate—Paget's disease of bone	0.000377	0.00188	CcSEcCtD
Celecoxib—Haematuria—Pamidronate—Paget's disease of bone	0.00037	0.00185	CcSEcCtD
Celecoxib—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.000369	0.00184	CcSEcCtD
Celecoxib—Haemoglobin—Risedronate—Paget's disease of bone	0.000368	0.00184	CcSEcCtD
Celecoxib—Anaemia—Alendronate—Paget's disease of bone	0.000367	0.00183	CcSEcCtD
Celecoxib—Rhinitis—Risedronate—Paget's disease of bone	0.000367	0.00183	CcSEcCtD
Celecoxib—Pollakiuria—Zoledronate—Paget's disease of bone	0.000367	0.00183	CcSEcCtD
Celecoxib—ABCC4—Ectoderm Differentiation—TNFRSF11B—Paget's disease of bone	0.000367	0.0106	CbGpPWpGaD
Celecoxib—Haemorrhage—Risedronate—Paget's disease of bone	0.000366	0.00183	CcSEcCtD
Celecoxib—MAPK14—B Cell Receptor Signaling Pathway—INPP5D—Paget's disease of bone	0.000366	0.0106	CbGpPWpGaD
Celecoxib—Sinusitis—Pamidronate—Paget's disease of bone	0.000364	0.00182	CcSEcCtD
Celecoxib—Pharyngitis—Risedronate—Paget's disease of bone	0.000364	0.00181	CcSEcCtD
Celecoxib—Angioedema—Alendronate—Paget's disease of bone	0.000363	0.00181	CcSEcCtD
Celecoxib—Agranulocytosis—Pamidronate—Paget's disease of bone	0.000362	0.00181	CcSEcCtD
Celecoxib—Urinary tract disorder—Risedronate—Paget's disease of bone	0.000362	0.00181	CcSEcCtD
Celecoxib—Weight increased—Zoledronate—Paget's disease of bone	0.000362	0.0018	CcSEcCtD
Celecoxib—Oedema peripheral—Risedronate—Paget's disease of bone	0.000361	0.0018	CcSEcCtD
Celecoxib—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00036	0.0018	CcSEcCtD
Celecoxib—Urethral disorder—Risedronate—Paget's disease of bone	0.000359	0.00179	CcSEcCtD
Celecoxib—Vertigo—Alendronate—Paget's disease of bone	0.000357	0.00178	CcSEcCtD
Celecoxib—Infestation NOS—Zoledronate—Paget's disease of bone	0.000354	0.00177	CcSEcCtD
Celecoxib—Infestation—Zoledronate—Paget's disease of bone	0.000354	0.00177	CcSEcCtD
Celecoxib—Haemoglobin—Pamidronate—Paget's disease of bone	0.00035	0.00175	CcSEcCtD
Celecoxib—Rhinitis—Pamidronate—Paget's disease of bone	0.000349	0.00174	CcSEcCtD
Celecoxib—Haemorrhage—Pamidronate—Paget's disease of bone	0.000348	0.00174	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.000347	0.00173	CcSEcCtD
Celecoxib—Stomatitis—Zoledronate—Paget's disease of bone	0.000345	0.00172	CcSEcCtD
Celecoxib—Urinary tract infection—Zoledronate—Paget's disease of bone	0.000344	0.00172	CcSEcCtD
Celecoxib—Conjunctivitis—Zoledronate—Paget's disease of bone	0.000344	0.00172	CcSEcCtD
Celecoxib—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.000344	0.00172	CcSEcCtD
Celecoxib—Eye disorder—Risedronate—Paget's disease of bone	0.000342	0.00171	CcSEcCtD
Celecoxib—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.000342	0.00171	CcSEcCtD
Celecoxib—Paraesthesia—Etidronic acid—Paget's disease of bone	0.000342	0.00171	CcSEcCtD
Celecoxib—Tinnitus—Risedronate—Paget's disease of bone	0.000342	0.0017	CcSEcCtD
Celecoxib—Urethral disorder—Pamidronate—Paget's disease of bone	0.000341	0.0017	CcSEcCtD
Celecoxib—Cardiac disorder—Risedronate—Paget's disease of bone	0.00034	0.0017	CcSEcCtD
Celecoxib—ALB—Folate Metabolism—CSF1—Paget's disease of bone	0.00034	0.00982	CbGpPWpGaD
Celecoxib—Chest pain—Alendronate—Paget's disease of bone	0.000338	0.00169	CcSEcCtD
Celecoxib—Myalgia—Alendronate—Paget's disease of bone	0.000338	0.00169	CcSEcCtD
Celecoxib—Haematuria—Zoledronate—Paget's disease of bone	0.000338	0.00169	CcSEcCtD
Celecoxib—Dyspepsia—Etidronic acid—Paget's disease of bone	0.000335	0.00167	CcSEcCtD
Celecoxib—Angiopathy—Risedronate—Paget's disease of bone	0.000332	0.00166	CcSEcCtD
Celecoxib—Immune system disorder—Risedronate—Paget's disease of bone	0.000331	0.00165	CcSEcCtD
Celecoxib—Agranulocytosis—Zoledronate—Paget's disease of bone	0.000331	0.00165	CcSEcCtD
Celecoxib—Mediastinal disorder—Risedronate—Paget's disease of bone	0.00033	0.00165	CcSEcCtD
Celecoxib—Arrhythmia—Risedronate—Paget's disease of bone	0.000327	0.00163	CcSEcCtD
Celecoxib—Constipation—Etidronic acid—Paget's disease of bone	0.000326	0.00162	CcSEcCtD
Celecoxib—Eye disorder—Pamidronate—Paget's disease of bone	0.000325	0.00162	CcSEcCtD
Celecoxib—Cardiac disorder—Pamidronate—Paget's disease of bone	0.000323	0.00161	CcSEcCtD
Celecoxib—Flushing—Pamidronate—Paget's disease of bone	0.000323	0.00161	CcSEcCtD
Celecoxib—Infection—Alendronate—Paget's disease of bone	0.000322	0.00161	CcSEcCtD
Celecoxib—Mental disorder—Risedronate—Paget's disease of bone	0.000321	0.0016	CcSEcCtD
Celecoxib—Hypoaesthesia—Zoledronate—Paget's disease of bone	0.000317	0.00158	CcSEcCtD
Celecoxib—Angiopathy—Pamidronate—Paget's disease of bone	0.000316	0.00158	CcSEcCtD
Celecoxib—Immune system disorder—Pamidronate—Paget's disease of bone	0.000315	0.00157	CcSEcCtD
Celecoxib—Flatulence—Risedronate—Paget's disease of bone	0.000314	0.00157	CcSEcCtD
Celecoxib—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.000314	0.00157	CcSEcCtD
Celecoxib—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.000314	0.00157	CcSEcCtD
Celecoxib—Feeling abnormal—Etidronic acid—Paget's disease of bone	0.000314	0.00157	CcSEcCtD
Celecoxib—Oedema peripheral—Zoledronate—Paget's disease of bone	0.000313	0.00156	CcSEcCtD
Celecoxib—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.000313	0.00156	CcSEcCtD
Celecoxib—Urethral disorder—Zoledronate—Paget's disease of bone	0.000312	0.00156	CcSEcCtD
Celecoxib—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.000311	0.00155	CcSEcCtD
Celecoxib—Back pain—Risedronate—Paget's disease of bone	0.000308	0.00154	CcSEcCtD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—SQSTM1—Paget's disease of bone	0.000308	0.00891	CbGpPWpGaD
Celecoxib—Alopecia—Pamidronate—Paget's disease of bone	0.000308	0.00154	CcSEcCtD
Celecoxib—Muscle spasms—Risedronate—Paget's disease of bone	0.000307	0.00153	CcSEcCtD
Celecoxib—Urticaria—Etidronic acid—Paget's disease of bone	0.000302	0.00151	CcSEcCtD
Celecoxib—Abdominal pain—Etidronic acid—Paget's disease of bone	0.000301	0.0015	CcSEcCtD
Celecoxib—MAPK14—BDNF signaling pathway—ALPL—Paget's disease of bone	0.0003	0.00869	CbGpPWpGaD
Celecoxib—Tension—Pamidronate—Paget's disease of bone	0.000297	0.00148	CcSEcCtD
Celecoxib—Eye disorder—Zoledronate—Paget's disease of bone	0.000297	0.00148	CcSEcCtD
Celecoxib—Dysgeusia—Pamidronate—Paget's disease of bone	0.000297	0.00148	CcSEcCtD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—PML—Paget's disease of bone	0.000296	0.00857	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.000296	0.00147	CcSEcCtD
Celecoxib—Cardiac disorder—Zoledronate—Paget's disease of bone	0.000295	0.00147	CcSEcCtD
Celecoxib—Flushing—Zoledronate—Paget's disease of bone	0.000295	0.00147	CcSEcCtD
Celecoxib—Anaemia—Risedronate—Paget's disease of bone	0.000295	0.00147	CcSEcCtD
Celecoxib—Nervousness—Pamidronate—Paget's disease of bone	0.000294	0.00147	CcSEcCtD
Celecoxib—Back pain—Pamidronate—Paget's disease of bone	0.000293	0.00146	CcSEcCtD
Celecoxib—Muscle spasms—Pamidronate—Paget's disease of bone	0.000291	0.00145	CcSEcCtD
Celecoxib—Angioedema—Risedronate—Paget's disease of bone	0.000291	0.00145	CcSEcCtD
Celecoxib—Angiopathy—Zoledronate—Paget's disease of bone	0.000289	0.00144	CcSEcCtD
Celecoxib—Immune system disorder—Zoledronate—Paget's disease of bone	0.000287	0.00143	CcSEcCtD
Celecoxib—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.000287	0.00143	CcSEcCtD
Celecoxib—Vertigo—Risedronate—Paget's disease of bone	0.000287	0.00143	CcSEcCtD
Celecoxib—Syncope—Risedronate—Paget's disease of bone	0.000286	0.00143	CcSEcCtD
Celecoxib—Dyspepsia—Alendronate—Paget's disease of bone	0.000286	0.00142	CcSEcCtD
Celecoxib—Arrhythmia—Zoledronate—Paget's disease of bone	0.000284	0.00142	CcSEcCtD
Celecoxib—Alopecia—Zoledronate—Paget's disease of bone	0.000281	0.0014	CcSEcCtD
Celecoxib—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00028	0.0014	CcSEcCtD
Celecoxib—Loss of consciousness—Risedronate—Paget's disease of bone	0.00028	0.0014	CcSEcCtD
Celecoxib—Anaemia—Pamidronate—Paget's disease of bone	0.00028	0.0014	CcSEcCtD
Celecoxib—Mental disorder—Zoledronate—Paget's disease of bone	0.000279	0.00139	CcSEcCtD
Celecoxib—Cough—Risedronate—Paget's disease of bone	0.000278	0.00139	CcSEcCtD
Celecoxib—Constipation—Alendronate—Paget's disease of bone	0.000277	0.00138	CcSEcCtD
Celecoxib—Angioedema—Pamidronate—Paget's disease of bone	0.000277	0.00138	CcSEcCtD
Celecoxib—Hypertension—Risedronate—Paget's disease of bone	0.000275	0.00137	CcSEcCtD
Celecoxib—Syncope—Pamidronate—Paget's disease of bone	0.000272	0.00136	CcSEcCtD
Celecoxib—Arthralgia—Risedronate—Paget's disease of bone	0.000272	0.00135	CcSEcCtD
Celecoxib—Myalgia—Risedronate—Paget's disease of bone	0.000272	0.00135	CcSEcCtD
Celecoxib—Chest pain—Risedronate—Paget's disease of bone	0.000272	0.00135	CcSEcCtD
Celecoxib—Leukopenia—Pamidronate—Paget's disease of bone	0.000271	0.00135	CcSEcCtD
Celecoxib—Dysgeusia—Zoledronate—Paget's disease of bone	0.000271	0.00135	CcSEcCtD
Celecoxib—Anxiety—Risedronate—Paget's disease of bone	0.000271	0.00135	CcSEcCtD
Celecoxib—ABCC4—NRF2 pathway—SQSTM1—Paget's disease of bone	0.00027	0.00781	CbGpPWpGaD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.00027	0.00135	CcSEcCtD
Celecoxib—Pruritus—Etidronic acid—Paget's disease of bone	0.000269	0.00134	CcSEcCtD
Celecoxib—Back pain—Zoledronate—Paget's disease of bone	0.000268	0.00134	CcSEcCtD
Celecoxib—Feeling abnormal—Alendronate—Paget's disease of bone	0.000267	0.00133	CcSEcCtD
Celecoxib—Loss of consciousness—Pamidronate—Paget's disease of bone	0.000266	0.00133	CcSEcCtD
Celecoxib—Muscle spasms—Zoledronate—Paget's disease of bone	0.000266	0.00133	CcSEcCtD
Celecoxib—PDPK1—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000266	0.00769	CbGpPWpGaD
Celecoxib—Dry mouth—Risedronate—Paget's disease of bone	0.000266	0.00132	CcSEcCtD
Celecoxib—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.000265	0.00132	CcSEcCtD
Celecoxib—Cough—Pamidronate—Paget's disease of bone	0.000265	0.00132	CcSEcCtD
Celecoxib—Hypertension—Pamidronate—Paget's disease of bone	0.000262	0.00131	CcSEcCtD
Celecoxib—Vision blurred—Zoledronate—Paget's disease of bone	0.000261	0.0013	CcSEcCtD
Celecoxib—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00026	0.0013	CcSEcCtD
Celecoxib—Infection—Risedronate—Paget's disease of bone	0.000259	0.00129	CcSEcCtD
Celecoxib—Myalgia—Pamidronate—Paget's disease of bone	0.000258	0.00129	CcSEcCtD
Celecoxib—Arthralgia—Pamidronate—Paget's disease of bone	0.000258	0.00129	CcSEcCtD
Celecoxib—Urticaria—Alendronate—Paget's disease of bone	0.000258	0.00129	CcSEcCtD
Celecoxib—Anxiety—Pamidronate—Paget's disease of bone	0.000257	0.00128	CcSEcCtD
Celecoxib—Abdominal pain—Alendronate—Paget's disease of bone	0.000256	0.00128	CcSEcCtD
Celecoxib—Body temperature increased—Alendronate—Paget's disease of bone	0.000256	0.00128	CcSEcCtD
Celecoxib—Shock—Risedronate—Paget's disease of bone	0.000256	0.00128	CcSEcCtD
Celecoxib—Anaemia—Zoledronate—Paget's disease of bone	0.000256	0.00128	CcSEcCtD
Celecoxib—Nervous system disorder—Risedronate—Paget's disease of bone	0.000255	0.00127	CcSEcCtD
Celecoxib—Angioedema—Zoledronate—Paget's disease of bone	0.000253	0.00126	CcSEcCtD
Celecoxib—Skin disorder—Risedronate—Paget's disease of bone	0.000253	0.00126	CcSEcCtD
Celecoxib—MAPK14—Cellular responses to stress—VCP—Paget's disease of bone	0.000252	0.00729	CbGpPWpGaD
Celecoxib—Confusional state—Pamidronate—Paget's disease of bone	0.000249	0.00124	CcSEcCtD
Celecoxib—Vertigo—Zoledronate—Paget's disease of bone	0.000249	0.00124	CcSEcCtD
Celecoxib—Syncope—Zoledronate—Paget's disease of bone	0.000248	0.00124	CcSEcCtD
Celecoxib—Leukopenia—Zoledronate—Paget's disease of bone	0.000248	0.00124	CcSEcCtD
Celecoxib—Oedema—Pamidronate—Paget's disease of bone	0.000247	0.00123	CcSEcCtD
Celecoxib—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.000247	0.00123	CcSEcCtD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—SQSTM1—Paget's disease of bone	0.000246	0.00712	CbGpPWpGaD
Celecoxib—Infection—Pamidronate—Paget's disease of bone	0.000246	0.00123	CcSEcCtD
Celecoxib—Palpitations—Zoledronate—Paget's disease of bone	0.000245	0.00122	CcSEcCtD
Celecoxib—Shock—Pamidronate—Paget's disease of bone	0.000243	0.00121	CcSEcCtD
Celecoxib—Loss of consciousness—Zoledronate—Paget's disease of bone	0.000243	0.00121	CcSEcCtD
Celecoxib—MAPK14—EGF/EGFR Signaling Pathway—INPP5D—Paget's disease of bone	0.000243	0.00702	CbGpPWpGaD
Celecoxib—Nervous system disorder—Pamidronate—Paget's disease of bone	0.000243	0.00121	CcSEcCtD
Celecoxib—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.000242	0.00121	CcSEcCtD
Celecoxib—Vomiting—Etidronic acid—Paget's disease of bone	0.000242	0.00121	CcSEcCtD
Celecoxib—Cough—Zoledronate—Paget's disease of bone	0.000242	0.00121	CcSEcCtD
Celecoxib—Tachycardia—Pamidronate—Paget's disease of bone	0.000241	0.0012	CcSEcCtD
Celecoxib—Rash—Etidronic acid—Paget's disease of bone	0.00024	0.0012	CcSEcCtD
Celecoxib—Dermatitis—Etidronic acid—Paget's disease of bone	0.00024	0.0012	CcSEcCtD
Celecoxib—Hyperhidrosis—Pamidronate—Paget's disease of bone	0.000239	0.00119	CcSEcCtD
Celecoxib—MAPK14—BDNF signaling pathway—SQSTM1—Paget's disease of bone	0.000239	0.00692	CbGpPWpGaD
Celecoxib—Hypertension—Zoledronate—Paget's disease of bone	0.000239	0.00119	CcSEcCtD
Celecoxib—Hypersensitivity—Alendronate—Paget's disease of bone	0.000239	0.00119	CcSEcCtD
Celecoxib—Headache—Etidronic acid—Paget's disease of bone	0.000238	0.00119	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.000237	0.00118	CcSEcCtD
Celecoxib—Anorexia—Pamidronate—Paget's disease of bone	0.000236	0.00118	CcSEcCtD
Celecoxib—Chest pain—Zoledronate—Paget's disease of bone	0.000236	0.00118	CcSEcCtD
Celecoxib—Arthralgia—Zoledronate—Paget's disease of bone	0.000236	0.00118	CcSEcCtD
Celecoxib—Myalgia—Zoledronate—Paget's disease of bone	0.000236	0.00118	CcSEcCtD
Celecoxib—Insomnia—Risedronate—Paget's disease of bone	0.000235	0.00117	CcSEcCtD
Celecoxib—Anxiety—Zoledronate—Paget's disease of bone	0.000235	0.00117	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.000234	0.00117	CcSEcCtD
Celecoxib—Paraesthesia—Risedronate—Paget's disease of bone	0.000234	0.00117	CcSEcCtD
Celecoxib—Asthenia—Alendronate—Paget's disease of bone	0.000233	0.00116	CcSEcCtD
Celecoxib—Dyspnoea—Risedronate—Paget's disease of bone	0.000232	0.00116	CcSEcCtD
Celecoxib—Dry mouth—Zoledronate—Paget's disease of bone	0.000231	0.00115	CcSEcCtD
Celecoxib—Pruritus—Alendronate—Paget's disease of bone	0.000229	0.00115	CcSEcCtD
Celecoxib—Dyspepsia—Risedronate—Paget's disease of bone	0.000229	0.00114	CcSEcCtD
Celecoxib—Confusional state—Zoledronate—Paget's disease of bone	0.000228	0.00114	CcSEcCtD
Celecoxib—Nausea—Etidronic acid—Paget's disease of bone	0.000226	0.00113	CcSEcCtD
Celecoxib—Oedema—Zoledronate—Paget's disease of bone	0.000226	0.00113	CcSEcCtD
Celecoxib—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.000226	0.00113	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.000225	0.00112	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.000225	0.00112	CcSEcCtD
Celecoxib—Infection—Zoledronate—Paget's disease of bone	0.000225	0.00112	CcSEcCtD
Celecoxib—Fatigue—Risedronate—Paget's disease of bone	0.000224	0.00112	CcSEcCtD
Celecoxib—Insomnia—Pamidronate—Paget's disease of bone	0.000224	0.00112	CcSEcCtD
Celecoxib—Constipation—Risedronate—Paget's disease of bone	0.000223	0.00111	CcSEcCtD
Celecoxib—Shock—Zoledronate—Paget's disease of bone	0.000222	0.00111	CcSEcCtD
Celecoxib—Paraesthesia—Pamidronate—Paget's disease of bone	0.000222	0.00111	CcSEcCtD
Celecoxib—Diarrhoea—Alendronate—Paget's disease of bone	0.000222	0.00111	CcSEcCtD
Celecoxib—Nervous system disorder—Zoledronate—Paget's disease of bone	0.000222	0.00111	CcSEcCtD
Celecoxib—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.000221	0.0011	CcSEcCtD
Celecoxib—Dyspnoea—Pamidronate—Paget's disease of bone	0.000221	0.0011	CcSEcCtD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000221	0.00638	CbGpPWpGaD
Celecoxib—Tachycardia—Zoledronate—Paget's disease of bone	0.000221	0.0011	CcSEcCtD
Celecoxib—Somnolence—Pamidronate—Paget's disease of bone	0.00022	0.0011	CcSEcCtD
Celecoxib—Skin disorder—Zoledronate—Paget's disease of bone	0.00022	0.0011	CcSEcCtD
Celecoxib—Hyperhidrosis—Zoledronate—Paget's disease of bone	0.000218	0.00109	CcSEcCtD
Celecoxib—Dyspepsia—Pamidronate—Paget's disease of bone	0.000218	0.00109	CcSEcCtD
Celecoxib—Anorexia—Zoledronate—Paget's disease of bone	0.000215	0.00107	CcSEcCtD
Celecoxib—Decreased appetite—Pamidronate—Paget's disease of bone	0.000215	0.00107	CcSEcCtD
Celecoxib—Dizziness—Alendronate—Paget's disease of bone	0.000215	0.00107	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.000214	0.00107	CcSEcCtD
Celecoxib—Fatigue—Pamidronate—Paget's disease of bone	0.000213	0.00106	CcSEcCtD
Celecoxib—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.000213	0.00106	CcSEcCtD
Celecoxib—Constipation—Pamidronate—Paget's disease of bone	0.000212	0.00106	CcSEcCtD
Celecoxib—Urticaria—Risedronate—Paget's disease of bone	0.000207	0.00103	CcSEcCtD
Celecoxib—Vomiting—Alendronate—Paget's disease of bone	0.000206	0.00103	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.000206	0.00103	CcSEcCtD
Celecoxib—Body temperature increased—Risedronate—Paget's disease of bone	0.000206	0.00103	CcSEcCtD
Celecoxib—Abdominal pain—Risedronate—Paget's disease of bone	0.000206	0.00103	CcSEcCtD
Celecoxib—Rash—Alendronate—Paget's disease of bone	0.000205	0.00102	CcSEcCtD
Celecoxib—Insomnia—Zoledronate—Paget's disease of bone	0.000204	0.00102	CcSEcCtD
Celecoxib—Dermatitis—Alendronate—Paget's disease of bone	0.000204	0.00102	CcSEcCtD
Celecoxib—Feeling abnormal—Pamidronate—Paget's disease of bone	0.000204	0.00102	CcSEcCtD
Celecoxib—Headache—Alendronate—Paget's disease of bone	0.000203	0.00101	CcSEcCtD
Celecoxib—Paraesthesia—Zoledronate—Paget's disease of bone	0.000203	0.00101	CcSEcCtD
Celecoxib—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.000202	0.00101	CcSEcCtD
Celecoxib—Dyspnoea—Zoledronate—Paget's disease of bone	0.000201	0.00101	CcSEcCtD
Celecoxib—Somnolence—Zoledronate—Paget's disease of bone	0.000201	0.001	CcSEcCtD
Celecoxib—Dyspepsia—Zoledronate—Paget's disease of bone	0.000199	0.000993	CcSEcCtD
Celecoxib—Decreased appetite—Zoledronate—Paget's disease of bone	0.000196	0.00098	CcSEcCtD
Celecoxib—Abdominal pain—Pamidronate—Paget's disease of bone	0.000196	0.000976	CcSEcCtD
Celecoxib—Body temperature increased—Pamidronate—Paget's disease of bone	0.000196	0.000976	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.000195	0.000974	CcSEcCtD
Celecoxib—Fatigue—Zoledronate—Paget's disease of bone	0.000195	0.000972	CcSEcCtD
Celecoxib—Constipation—Zoledronate—Paget's disease of bone	0.000193	0.000964	CcSEcCtD
Celecoxib—Nausea—Alendronate—Paget's disease of bone	0.000193	0.000961	CcSEcCtD
Celecoxib—Hypersensitivity—Risedronate—Paget's disease of bone	0.000192	0.000957	CcSEcCtD
Celecoxib—MAPK14—Metabolism of RNA—NUP205—Paget's disease of bone	0.000191	0.00554	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—INPP5D—Paget's disease of bone	0.000188	0.00543	CbGpPWpGaD
Celecoxib—Asthenia—Risedronate—Paget's disease of bone	0.000187	0.000932	CcSEcCtD
Celecoxib—Feeling abnormal—Zoledronate—Paget's disease of bone	0.000186	0.000929	CcSEcCtD
Celecoxib—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.000185	0.000922	CcSEcCtD
Celecoxib—Pruritus—Risedronate—Paget's disease of bone	0.000184	0.000919	CcSEcCtD
Celecoxib—Hypersensitivity—Pamidronate—Paget's disease of bone	0.000182	0.00091	CcSEcCtD
Celecoxib—Urticaria—Zoledronate—Paget's disease of bone	0.00018	0.000896	CcSEcCtD
Celecoxib—Abdominal pain—Zoledronate—Paget's disease of bone	0.000179	0.000891	CcSEcCtD
Celecoxib—Body temperature increased—Zoledronate—Paget's disease of bone	0.000179	0.000891	CcSEcCtD
Celecoxib—Diarrhoea—Risedronate—Paget's disease of bone	0.000178	0.000889	CcSEcCtD
Celecoxib—Asthenia—Pamidronate—Paget's disease of bone	0.000178	0.000886	CcSEcCtD
Celecoxib—Pruritus—Pamidronate—Paget's disease of bone	0.000175	0.000873	CcSEcCtD
Celecoxib—Dizziness—Risedronate—Paget's disease of bone	0.000172	0.000859	CcSEcCtD
Celecoxib—Diarrhoea—Pamidronate—Paget's disease of bone	0.000169	0.000845	CcSEcCtD
Celecoxib—Hypersensitivity—Zoledronate—Paget's disease of bone	0.000167	0.000831	CcSEcCtD
Celecoxib—Vomiting—Risedronate—Paget's disease of bone	0.000165	0.000826	CcSEcCtD
Celecoxib—Rash—Risedronate—Paget's disease of bone	0.000164	0.000819	CcSEcCtD
Celecoxib—Dermatitis—Risedronate—Paget's disease of bone	0.000164	0.000818	CcSEcCtD
Celecoxib—Dizziness—Pamidronate—Paget's disease of bone	0.000164	0.000816	CcSEcCtD
Celecoxib—Headache—Risedronate—Paget's disease of bone	0.000163	0.000814	CcSEcCtD
Celecoxib—PDPK1—Adaptive Immune System—INPP5D—Paget's disease of bone	0.000162	0.0047	CbGpPWpGaD
Celecoxib—Asthenia—Zoledronate—Paget's disease of bone	0.000162	0.000809	CcSEcCtD
Celecoxib—Pruritus—Zoledronate—Paget's disease of bone	0.00016	0.000798	CcSEcCtD
Celecoxib—Vomiting—Pamidronate—Paget's disease of bone	0.000157	0.000785	CcSEcCtD
Celecoxib—Rash—Pamidronate—Paget's disease of bone	0.000156	0.000778	CcSEcCtD
Celecoxib—Dermatitis—Pamidronate—Paget's disease of bone	0.000156	0.000778	CcSEcCtD
Celecoxib—Headache—Pamidronate—Paget's disease of bone	0.000155	0.000773	CcSEcCtD
Celecoxib—Diarrhoea—Zoledronate—Paget's disease of bone	0.000155	0.000772	CcSEcCtD
Celecoxib—Nausea—Risedronate—Paget's disease of bone	0.000155	0.000771	CcSEcCtD
Celecoxib—Dizziness—Zoledronate—Paget's disease of bone	0.000149	0.000746	CcSEcCtD
Celecoxib—Nausea—Pamidronate—Paget's disease of bone	0.000147	0.000733	CcSEcCtD
Celecoxib—Vomiting—Zoledronate—Paget's disease of bone	0.000144	0.000717	CcSEcCtD
Celecoxib—Rash—Zoledronate—Paget's disease of bone	0.000142	0.000711	CcSEcCtD
Celecoxib—Dermatitis—Zoledronate—Paget's disease of bone	0.000142	0.00071	CcSEcCtD
Celecoxib—CA14—Metabolism—NUP205—Paget's disease of bone	0.000142	0.0041	CbGpPWpGaD
Celecoxib—Headache—Zoledronate—Paget's disease of bone	0.000142	0.000706	CcSEcCtD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—PML—Paget's disease of bone	0.000141	0.00408	CbGpPWpGaD
Celecoxib—PDPK1—Disease—VCP—Paget's disease of bone	0.00014	0.00404	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—SQSTM1—Paget's disease of bone	0.000138	0.00399	CbGpPWpGaD
Celecoxib—CA6—Metabolism—NUP205—Paget's disease of bone	0.000138	0.00399	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—NUP205—Paget's disease of bone	0.000138	0.00399	CbGpPWpGaD
Celecoxib—Nausea—Zoledronate—Paget's disease of bone	0.000134	0.00067	CcSEcCtD
Celecoxib—CA5B—Metabolism—NUP205—Paget's disease of bone	0.000129	0.00373	CbGpPWpGaD
Celecoxib—CA14—Metabolism—INPP5D—Paget's disease of bone	0.000121	0.00349	CbGpPWpGaD
Celecoxib—CA12—Metabolism—NUP205—Paget's disease of bone	0.000119	0.00345	CbGpPWpGaD
Celecoxib—CA5A—Metabolism—INPP5D—Paget's disease of bone	0.000118	0.0034	CbGpPWpGaD
Celecoxib—CA6—Metabolism—INPP5D—Paget's disease of bone	0.000118	0.0034	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NUP205—Paget's disease of bone	0.000116	0.00334	CbGpPWpGaD
Celecoxib—ABCC4—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	0.000113	0.00327	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—INPP5D—Paget's disease of bone	0.000111	0.00322	CbGpPWpGaD
Celecoxib—CA5B—Metabolism—INPP5D—Paget's disease of bone	0.00011	0.00318	CbGpPWpGaD
Celecoxib—PDPK1—Disease—NUP205—Paget's disease of bone	0.000107	0.00308	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CALCA—Paget's disease of bone	0.000103	0.00299	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—PML—Paget's disease of bone	0.000102	0.00295	CbGpPWpGaD
Celecoxib—CA12—Metabolism—INPP5D—Paget's disease of bone	0.000102	0.00294	CbGpPWpGaD
Celecoxib—ALB—SLC-mediated transmembrane transport—NUP205—Paget's disease of bone	0.000101	0.00292	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—INPP5D—Paget's disease of bone	9.85e-05	0.00285	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—VCP—Paget's disease of bone	9.77e-05	0.00283	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—INPP5D—Paget's disease of bone	9.76e-05	0.00282	CbGpPWpGaD
Celecoxib—CA4—Metabolism—NUP205—Paget's disease of bone	9.52e-05	0.00275	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CALCA—Paget's disease of bone	9.38e-05	0.00271	CbGpPWpGaD
Celecoxib—CA2—Metabolism—NUP205—Paget's disease of bone	9.13e-05	0.00264	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—SQSTM1—Paget's disease of bone	8.83e-05	0.00255	CbGpPWpGaD
Celecoxib—CA4—Metabolism—INPP5D—Paget's disease of bone	8.12e-05	0.00235	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CALCA—Paget's disease of bone	7.92e-05	0.00229	CbGpPWpGaD
Celecoxib—CA2—Metabolism—INPP5D—Paget's disease of bone	7.78e-05	0.00225	CbGpPWpGaD
Celecoxib—CA9—Metabolism—NUP205—Paget's disease of bone	7.69e-05	0.00222	CbGpPWpGaD
Celecoxib—CA9—Metabolism—INPP5D—Paget's disease of bone	6.56e-05	0.0019	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NUP205—Paget's disease of bone	6e-05	0.00174	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—NUP205—Paget's disease of bone	5.97e-05	0.00173	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SQSTM1—Paget's disease of bone	5.71e-05	0.00165	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	5.68e-05	0.00164	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CALCA—Paget's disease of bone	5.54e-05	0.0016	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—PML—Paget's disease of bone	5.31e-05	0.00153	CbGpPWpGaD
Celecoxib—ALB—Transmembrane transport of small molecules—NUP205—Paget's disease of bone	5.12e-05	0.00148	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—INPP5D—Paget's disease of bone	5.12e-05	0.00148	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—VCP—Paget's disease of bone	5.08e-05	0.00147	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—INPP5D—Paget's disease of bone	5.05e-05	0.00146	CbGpPWpGaD
Celecoxib—PTGS2—Disease—VCP—Paget's disease of bone	4.63e-05	0.00134	CbGpPWpGaD
Celecoxib—ALB—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	4.59e-05	0.00133	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—SQSTM1—Paget's disease of bone	4.59e-05	0.00133	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism of lipids and lipoproteins—INPP5D—Paget's disease of bone	3.76e-05	0.00109	CbGpPWpGaD
Celecoxib—PTGS2—Disease—NUP205—Paget's disease of bone	3.54e-05	0.00102	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SQSTM1—Paget's disease of bone	2.97e-05	0.000858	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—NUP205—Paget's disease of bone	2.97e-05	0.000858	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CALCA—Paget's disease of bone	2.88e-05	0.000833	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CALCA—Paget's disease of bone	2.63e-05	0.00076	CbGpPWpGaD
Celecoxib—PTGS2—Metabolism—INPP5D—Paget's disease of bone	2.53e-05	0.000731	CbGpPWpGaD
Celecoxib—ALB—Metabolism—NUP205—Paget's disease of bone	2.4e-05	0.000694	CbGpPWpGaD
Celecoxib—ALB—Metabolism—INPP5D—Paget's disease of bone	2.05e-05	0.000592	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—NUP205—Paget's disease of bone	1.98e-05	0.000573	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—NUP205—Paget's disease of bone	1.96e-05	0.000568	CbGpPWpGaD
Celecoxib—CYP2D6—Metabolism—INPP5D—Paget's disease of bone	1.69e-05	0.000488	CbGpPWpGaD
Celecoxib—CYP2C9—Metabolism—INPP5D—Paget's disease of bone	1.67e-05	0.000484	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—NUP205—Paget's disease of bone	1.29e-05	0.000375	CbGpPWpGaD
Celecoxib—CYP3A4—Metabolism—INPP5D—Paget's disease of bone	1.1e-05	0.000319	CbGpPWpGaD
